Tuesday, May 26, 2020

Biocon gets drug regulator#39;s nod for CytoSorb device to treat critical COVID-19 patients

Biocon gets drug regulator#39;s nod for CytoSorb device to treat critical COVID-19 patients "The goal of CytoSorb therapy is to reduce cytokine storm and the deadly inflammatory response through blood purification so that this injury may be mitigated or prevented," the company added.

from Moneycontrol Business News https://ift.tt/3gtAGyI

No comments:

Post a Comment

Nifty eyes relief rally on tariff hopes, FIIs remain a drag

Markets anticipate a rebound early in the shortened week following news of potential tariff removal on India. Despite oversold conditions, a...